Search Results - "Bowden, C L"

General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial by Kemp, D. E., Sylvia, L. G., Calabrese, J. R., Nierenberg, A. A., Thase, M. E., Reilly-Harrington, N. A., Ostacher, M. J., Leon, A. C., Ketter, T. A., Friedman, E. S., Bowden, C. L., Rabideau, D. J., Pencina, M., Iosifescu, D. V.

“…Objective This study examined general medical illnesses and their association with clinical features of bipolar disorder. Method Data were cross‐sectional and…”
Get full text

Trait impulsivity in patients with mood disorders by Peluso, M.A.M, Hatch, J.P, Glahn, D.C, Monkul, E.S, Sanches, M, Najt, P, Bowden, C.L, Barratt, E.S, Soares, J.C

“…Abstract Background Impulsivity is a key component of the manic behavior of bipolar disorder and is reported to occur in bipolar patients as a stable…”
Get full text

Valproate in bipolar disorder: 2000 onwards by Bowden, C. L., Singh, V.

“…Objective:  To describe the evidence for the efficacy and tolerability of valproate in treatment of bipolar disorders, as well as factors associated with…”
Get full text

Valproate for the treatment of acute bipolar depression: Systematic review and meta-analysis by Smith, L.A, Cornelius, V.R, Azorin, J.M, Perugi, G, Vieta, E, Young, A.H, Bowden, C.L

“…Abstract Background Our aim was to analyse existing data on the efficacy and tolerability of valproate for the treatment of acute bipolar depression. Methods…”
Get full text

Are bipolar disorders underdiagnosed in patients with depressive episodes? Results of the multicenter BRIDGE screening study in Germany by Bschor, T, Angst, J, Azorin, J.M, Bowden, C.L, Perugi, G, Vieta, E, Young, A.H, Krüger, S

“…Abstract Background Recent reports indicate that the prevalence of bipolar disorder (BD) in patients with an acute major depressive episode might be higher…”
Get full text

Development of the Bipolar Inventory of Symptoms Scale by Bowden, C. L., Singh, V., Thompson, P., Gonzalez, J. M., Katz, M. M., Dahl, M., Prihoda, T. J., Chang, X.

“…Objective:  Most rating scales for bipolar disorders (BDs) do not encompass the spectrum of symptomatology now established as characterizing the illness. We…”
Get full text

Lamotrigine vs. lamotrigine plus divalproex in randomized, placebo‐controlled maintenance treatment for bipolar depression by Bowden, C. L., Singh, V., Weisler, R., Thompson, P., Chang, X., Quinones, M., Mintz, J.

“…Bowden CL, Singh V, Weisler R, Thompson P, Chang X, Quinones M, Mintz J. Lamotrigine vs. lamotrigine plus divalproex in randomized, placebo‐controlled…”
Get full text

Relationships between mixed features and borderline personality disorder in 2811 patients with major depressive episode by Perugi, G., Angst, J., Azorin, J.-M., Bowden, C. L., Caciagli, A., Mosolov, S., Vieta, E., Young, A. H.

“…Objective The study focused on the relationship between mixed depression and borderline personality disorder (BPD). Method The sample comprised 2811 patients…”
Get full text

Evidence-based definitions of bipolar-I and bipolar-II disorders among 5,635 patients with major depressive episodes in the Bridge Study: validity and comorbidity by Angst, J., Gamma, A., Bowden, C. L., Azorin, J. M., Perugi, G., Vieta, E., Young, A. H.

“…The definitions of bipolar-I (BP-I) and bipolar-II (BP-II) disorders are currently under revision by the APA and by the WHO. We provide evidence of a revised…”
Get full text

Medication adherence in a comparative effectiveness trial for bipolar disorder by Sylvia, L. G., Reilly-Harrington, N. A., Leon, A. C., Kansky, C. I., Calabrese, J. R., Bowden, C. L., Ketter, T. A., Friedman, E. S., Iosifescu, D. V., Thase, M. E., Ostacher, M. J., Keyes, M., Rabideau, D., Nierenberg, A. A.

“…Objective Psychopharmacology remains the foundation of treatment for bipolar disorder, but medication adherence in this population is low (range 20–64%). We…”
Get full text

Double-Blind, Placebo-Controlled Comparison of Imipramine and Paroxetine in the Treatment of Bipolar Depression by Nemeroff, Charles B., Evans, Dwight L., Gyulai, Laszlo, Sachs, Gary S., Bowden, Charles L., Gergel, Ivan P., Oakes, Rosemary, Pitts, Cornelius D.

“…OBJECTIVE: This study compared the efficacy and safety of paroxetine and imipramine with that of placebo in the treatment of bipolar depression in adult…”
Get full text

Diagnostic criteria for bipolarity based on an international sample of 5,635 patients with DSM-IV major depressive episodes by Angst, J., Gamma, A., Bowden, C. L., Azorin, J. M., Perugi, G., Vieta, E., Young, A. H.

“…To assess the clinical validity of individual DSM-IV criteria for hypomania. In an international sample of 5,635 patients with major depressive episodes…”
Get full text

Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder by McElroy, S. L., Kemp, D. E., Friedman, E. S., Reilly-Harrington, N. A., Sylvia, L. G., Calabrese, J. R., Rabideau, D. J., Ketter, T. A., Thase, M. E., Singh, V., Tohen, M., Bowden, C. L., Bernstein, E. E., Brody, B. D., Deckersbach, T., Kocsis, J. H., Kinrys, G., Bobo, W. V., Kamali, M., McInnis, M. G., Leon, A. C., Faraone, S., Nierenberg, A. A., Shelton, R. C.

“…Objective Examine the effects of obesity and metabolic syndrome on outcome in bipolar disorder. Method The Comparative Effectiveness of a Second Generation…”
Get full text

Discriminating primary clinical states in bipolar disorder with a comprehensive symptom scale by Singh, V., Bowden, C. L., Gonzalez, J. M., Thompson, P., Prihoda, T. J., Katz, M. M., Bernardo, C. G.

“…Objective:  We assessed the spectrum and severity of bipolar symptoms that differentiated bipolar disorder (BD) clinical states, employing the Bipolar…”
Get full text

Strategies to Reduce Misdiagnosis of Bipolar Depression by Bowden, Charles L.

“…Research over the past decade indicates that the prevalence of bipolar disorder is similar to that of major depression. The author discusses complexities in…”
Get full text

Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies by Frye, M. A., Yatham, L., Ketter, T. A., Goldberg, J., Suppes, T., Calabrese, J. R., Bowden, C. L., Bourne, E., Bahn, R. S., Adams, B.

“…Objective:  To assess the relationship between depressive relapse and change in thyroid function in an exploratory post hoc analysis from a controlled…”
Get full text

Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: Contrasting LiTMUS baseline data with pre-existing placebo controlled trials by Friedman, E.S, Calabrese, J.R, Ketter, T.A, Leon, A.C, Thase, M.E, Bowden, C.L, Sylvia, L.G, Ostracher, M.J, Severe, J, Iosifescu, D.V, Nierenberg, A.A, Reilly-Harrington, N.A

“…Abstract Background Efficacy-based double-blind placebo controlled trials were conducted to establish efficacy and safety for FDA approval. Such designs…”
Get full text

Combination of a Mood Stabilizer With Risperidone or Haloperidol for Treatment of Acute Mania: A Double-Blind, Placebo-Controlled Comparison of Efficacy and Safety by Sachs, Gary S., Grossman, Fred, Ghaemi, S. Nassir, Okamoto, Akiko, Bowden, Charles L.

“…OBJECTIVE: The study assessed the efficacy and safety of risperidone as an adjunctive agent to mood stabilizers in the treatment of acute mania. METHOD: This…”
Get full text

Spectrum of Activity of Lamotrigine in Treatment-Refractory Bipolar Disorder by Calabrese, Joseph R., Bowden, Charles L., McElroy, Susan L., Cookson, John, Andersen, John, Keck, Jr, Paul E., Rhodes, Linda, Bolden-Watson, Carolyn, Zhou, Jing, Ascher, John A.

“…OBJECTIVE: New mood stabilizers are needed that possess efficacy for all phases of bipolar disorder. This study was designed to provide preliminary evidence…”
Get full text

Aims and Results of the NIMH Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) by Bowden, C.L., Perlis, R.H., Thase, M.E., Ketter, T.A., Ostacher, M.M., Calabrese, J.R., Reilly-Harrington, N.A., Gonzalez, J.M., Singh, V., Nierenberg, A.A., Sachs, G.S.

“…SUMMARY The Systematic Treatment Enhancement Program for Bipolar Disorder (STEP‐BD) was funded as part of a National Institute of Mental Health initiative to…”
Get full text